Claudie Laprise

Summary

Country: Canada

Publications

  1. pmc Atazanavir and other determinants of hyperbilirubinemia in a cohort of 1150 HIV-positive patients: results from 9 years of follow-up
    Claudie Laprise
    Department of Social and Preventive Medicine, Universite de Montreal, Montreal, Quebec, Canada
    AIDS Patient Care STDS 27:378-86. 2013
  2. doi Association between tenofovir exposure and reduced kidney function in a cohort of HIV-positive patients: results from 10 years of follow-up
    Claudie Laprise
    Department of Social and Preventive Medicine, University of Montreal, Montreal, Quebec, Canada
    Clin Infect Dis 56:567-75. 2013
  3. doi Virologic failure following persistent low-level viremia in a cohort of HIV-positive patients: results from 12 years of observation
    Claudie Laprise
    Department of Social and Preventive Medicine, University of Montreal, Sainte Justine Hospital Research Center
    Clin Infect Dis 57:1489-96. 2013
  4. doi No role for human papillomavirus infection in oral cancers in a region in southern India
    Claudie Laprise
    Division of Cancer Epidemiology, Department of Oncology, McGill University, Montreal, QC, Canada
    Int J Cancer 138:912-7. 2016
  5. doi Prevalence of human papillomaviruses in semen: a systematic review and meta-analysis
    Claudie Laprise
    Department of Social and Preventive Medicine, Universite de Montreal, 7101 Avenue du Parc, Montreal, QC, Canada H3N 1X7
    Hum Reprod 29:640-51. 2014

Collaborators

Detail Information

Publications5

  1. pmc Atazanavir and other determinants of hyperbilirubinemia in a cohort of 1150 HIV-positive patients: results from 9 years of follow-up
    Claudie Laprise
    Department of Social and Preventive Medicine, Universite de Montreal, Montreal, Quebec, Canada
    AIDS Patient Care STDS 27:378-86. 2013
    ..Importantly, long-term hyperbilirubinemia was not associated with adverse health outcome...
  2. doi Association between tenofovir exposure and reduced kidney function in a cohort of HIV-positive patients: results from 10 years of follow-up
    Claudie Laprise
    Department of Social and Preventive Medicine, University of Montreal, Montreal, Quebec, Canada
    Clin Infect Dis 56:567-75. 2013
    ....
  3. doi Virologic failure following persistent low-level viremia in a cohort of HIV-positive patients: results from 12 years of observation
    Claudie Laprise
    Department of Social and Preventive Medicine, University of Montreal, Sainte Justine Hospital Research Center
    Clin Infect Dis 57:1489-96. 2013
    ..Our objective was to study the long-term impact of persistent LLV on the subsequent risk of virologic failure in a cohort of people living with HIV in Montreal, Canada...
  4. doi No role for human papillomavirus infection in oral cancers in a region in southern India
    Claudie Laprise
    Division of Cancer Epidemiology, Department of Oncology, McGill University, Montreal, QC, Canada
    Int J Cancer 138:912-7. 2016
    ..A nationwide representative prevalence study is needed to investigate HPV prevalence variability among Indian regions. ..
  5. doi Prevalence of human papillomaviruses in semen: a systematic review and meta-analysis
    Claudie Laprise
    Department of Social and Preventive Medicine, Universite de Montreal, 7101 Avenue du Parc, Montreal, QC, Canada H3N 1X7
    Hum Reprod 29:640-51. 2014
    ..What is the prevalence of human papillomavirus (HPV) in semen?..